Nurse Recruiting International

International Nurses, Physical Therapists, Occupational Therapists, Employment based US Immigration, Health Care Recruiting and Placement.

Name:
Location: Grand Rapids, Michigan, United States

Monday, February 13, 2006

NCLEX-RN EXAMINATIONS - INTERNATIONAL TESTING SITES

February 09, 2006. The national Council of State Boards of Nursing (NCSBN), www.ncsbn.org will begin NCLEX-RN testing at the newly selected international Pearson Professional centers on April 01, 2006. Appointments for testing will begin on February 15, 2006.

The new centers will be located in Sydney, Australia; Toronto, Montreal, and Vancouver, Canada; Frankfurt, Germany; Mumbai, New Delhi, Hyderabad, Bangalore, and Chennai, India; Mexico City, Mexico; Chiyoda-ku, and Yokohoma, Japan; and Taipei, Taiwan. These sites are in addition to centers in London, England; Seoul, South Korea; and Hong Kong, which have been operational since January 2005.

Administration of the NCLEX-RN examination overseas does not contradict or circumvent any current board of nursing process or requirement. All international candidates are required to apply to the board of nursing in the state or territory where they wish to be licensed before registering for the NCLEX-RN examination. Candidates who elect to take the NCLEX-RN exam at an international site will pay an extra US$150.00 when scheduling the exam, in addition to the NCLEX-RN exam fee of US$200.00.

Wednesday, February 08, 2006

NEW INTERNATIONAL TEST LOCATIONS FOR NCLEX-RN

US Nurse Licensing Exam, NCLEX-RN Offerred in New International Locations.

January 24, 2006. The National Council of State Boards of Nursing (NCSBN),
www.ncsbn.org announced that it would expand international sites that offer the NCLEX-RN examinations to include countries: Australia, Canada, Germany, India, Japan, Mexico, and Taiwan.

The exact test locations within each country, nor an implementation date have been announced.
In January 2005, NCSBN began offering NCLEX exam internationally, in London, England; Seoul, South Korea; and Hong Kong.